Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bamford CC et al. - Treatment should always begin with low doses and be gradually increased to optimal dosing, which then should be maintained for 2 to 3 months to evaluate effectiveness. Medications with the best evidence for efficacy in the prevention of migraine are amitriptyline, propranolol, timolol, valproate, and topiramate. Although all migraine preventive medications are nonspecific and have multiple potential mechanisms for their effects, they often share a tendency to reduce central neuronal hyperexcitability by inhibiting excitatory neurotransmitters, such as glutamate and norepinephrine, increasing inhibitory tone via GABA, reducing the likelihood of cortical spreading depression, or favorably altering channelopathies or mitochondriopathies thought to be intrinsic to migraine pathophysiology.

Related Articles

Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09    Relevance Score: 69%

Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09    Relevance Score: 69%

Urinary 6-Sulphatoxymelatonin Levels Are Depressed in Chronic Migraine and Several Comorbidities
Headache: The Journal of Head and Face Pain, 10/12/09    Relevance Score: 68%

Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting
The Journal of Headache and Pain, 11/10/09    Relevance Score: 67%

Expanding Access to Triptans: Assessment of Clinical Outcome
Headache: The Journal of Head and Face Pain, 10/12/09    Relevance Score: 66%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address